[SIMEPROP] QoQ Annualized Quarter Result on 30-Jun-2024 [#2]

Stock
[SIMEPROP] SIME DARBY PROPERTY BERHAD
Announcement Date
22-Aug-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Jun-2024 [#2]
Profit Trend
QoQ- 15.53%
YoY- 116.75%
Quarter Report
Latest QR
Upcoming QR
SIMEPROP's Result
SIMEPROP's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 4,363,750 3,914,764 3,436,947 3,232,326 2,748,500 2,741,328 2,742,136 36.34%
PBT 892,678 723,196 610,306 587,658 424,446 391,744 458,860 55.90%
Tax -306,540 -213,836 -192,776 -208,577 -144,378 -146,964 -147,162 63.17%
NP 586,138 509,360 417,530 379,081 280,068 244,780 311,698 52.40%
-
NP to SH 571,082 494,328 407,914 368,873 263,480 242,688 315,839 48.47%
-
Tax Rate 34.34% 29.57% 31.59% 35.49% 34.02% 37.52% 32.07% -
Total Cost 3,777,612 3,405,404 3,019,417 2,853,245 2,468,432 2,496,548 2,430,438 34.21%
-
Net Worth 10,269,266 10,133,250 10,065,241 9,861,216 9,861,216 9,589,182 9,521,174 5.17%
Dividend
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Div 204,025 - 170,020 90,677 136,016 - 136,016 31.06%
Div Payout % 35.73% - 41.68% 24.58% 51.62% - 43.07% -
Equity
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Net Worth 10,269,266 10,133,250 10,065,241 9,861,216 9,861,216 9,589,182 9,521,174 5.17%
NOSH 6,800,839 6,800,839 6,800,839 6,800,839 6,800,839 6,800,839 6,800,839 0.00%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 13.43% 13.01% 12.15% 11.73% 10.19% 8.93% 11.37% -
ROE 5.56% 4.88% 4.05% 3.74% 2.67% 2.53% 3.32% -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
RPS 64.16 57.56 50.54 47.53 40.41 40.31 40.32 36.33%
EPS 8.40 7.20 6.00 5.47 3.80 3.60 4.60 49.45%
DPS 3.00 0.00 2.50 1.33 2.00 0.00 2.00 31.06%
NAPS 1.51 1.49 1.48 1.45 1.45 1.41 1.40 5.17%
Adjusted Per Share Value based on latest NOSH - 6,800,839
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
RPS 64.16 57.56 50.54 47.53 40.41 40.31 40.32 36.33%
EPS 8.40 7.20 6.00 5.47 3.80 3.60 4.60 49.45%
DPS 3.00 0.00 2.50 1.33 2.00 0.00 2.00 31.06%
NAPS 1.51 1.49 1.48 1.45 1.45 1.41 1.40 5.17%
Price Multiplier on Financial Quarter End Date
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Date 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 -
Price 1.34 0.915 0.625 0.695 0.465 0.485 0.45 -
P/RPS 2.09 1.59 1.24 1.46 1.15 1.20 1.12 51.62%
P/EPS 15.96 12.59 10.42 12.81 12.00 13.59 9.69 39.50%
EY 6.27 7.94 9.60 7.80 8.33 7.36 10.32 -28.28%
DY 2.24 0.00 4.00 1.92 4.30 0.00 4.44 -36.65%
P/NAPS 0.89 0.61 0.42 0.48 0.32 0.34 0.32 97.89%
Price Multiplier on Announcement Date
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Date 22/08/24 21/05/24 23/02/24 24/11/23 28/08/23 25/05/23 28/02/23 -
Price 1.41 1.07 0.795 0.62 0.69 0.465 0.48 -
P/RPS 2.20 1.86 1.57 1.30 1.71 1.15 1.19 50.68%
P/EPS 16.79 14.72 13.25 11.43 17.81 13.03 10.34 38.19%
EY 5.96 6.79 7.54 8.75 5.61 7.67 9.68 -27.64%
DY 2.13 0.00 3.14 2.15 2.90 0.00 4.17 -36.12%
P/NAPS 0.93 0.72 0.54 0.43 0.48 0.33 0.34 95.70%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment